ATYR
Price
$5.72
Change
-$0.27 (-4.51%)
Updated
Jul 21, 03:48 PM (EDT)
Capitalization
533.14M
23 days until earnings call
RZLT
Price
$5.39
Change
-$0.00 (-0.00%)
Updated
Jul 21, 04:39 PM (EDT)
Capitalization
467.93M
52 days until earnings call
Interact to see
Advertisement

ATYR vs RZLT

Header iconATYR vs RZLT Comparison
Open Charts ATYR vs RZLTBanner chart's image
aTyr Pharma
Price$5.72
Change-$0.27 (-4.51%)
Volume$476
Capitalization533.14M
Rezolute
Price$5.39
Change-$0.00 (-0.00%)
Volume$385
Capitalization467.93M
ATYR vs RZLT Comparison Chart in %
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. RZLT commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and RZLT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ATYR: $5.99 vs. RZLT: $5.39)
Brand notoriety: ATYR and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 164% vs. RZLT: 59%
Market capitalization -- ATYR: $533.14M vs. RZLT: $467.93M
ATYR [@Biotechnology] is valued at $533.14M. RZLT’s [@Biotechnology] market capitalization is $467.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileRZLT’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • RZLT’s FA Score: 0 green, 5 red.
According to our system of comparison, RZLT is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 4 TA indicator(s) are bullish while RZLT’s TA Score has 4 bullish TA indicator(s).

  • ATYR’s TA Score: 4 bullish, 4 bearish.
  • RZLT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RZLT is a better buy in the short-term than ATYR.

Price Growth

ATYR (@Biotechnology) experienced а +12.81% price change this week, while RZLT (@Biotechnology) price change was +2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

ATYR is expected to report earnings on Aug 13, 2025.

RZLT is expected to report earnings on Sep 11, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR($533M) has a higher market cap than RZLT($468M). ATYR YTD gains are higher at: 65.470 vs. RZLT (10.000). ATYR has higher annual earnings (EBITDA): -65.9M vs. RZLT (-77.12M). RZLT has more cash in the bank: 86.9M vs. ATYR (76.3M). RZLT has less debt than ATYR: RZLT (1.78M) vs ATYR (13M). ATYR (0) and RZLT (0) have equivalent revenues.
ATYRRZLTATYR / RZLT
Capitalization533M468M114%
EBITDA-65.9M-77.12M85%
Gain YTD65.47010.000655%
P/E RatioN/AN/A-
Revenue00-
Total Cash76.3M86.9M88%
Total Debt13M1.78M732%
FUNDAMENTALS RATINGS
ATYR vs RZLT: Fundamental Ratings
ATYR
RZLT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3537
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (50) in the null industry is somewhat better than the same rating for ATYR (83). This means that RZLT’s stock grew somewhat faster than ATYR’s over the last 12 months.

RZLT's Profit vs Risk Rating (100) in the null industry is in the same range as ATYR (100). This means that RZLT’s stock grew similarly to ATYR’s over the last 12 months.

RZLT's SMR Rating (98) in the null industry is in the same range as ATYR (100). This means that RZLT’s stock grew similarly to ATYR’s over the last 12 months.

ATYR's Price Growth Rating (35) in the null industry is in the same range as RZLT (37). This means that ATYR’s stock grew similarly to RZLT’s over the last 12 months.

ATYR's P/E Growth Rating (100) in the null industry is in the same range as RZLT (100). This means that ATYR’s stock grew similarly to RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATYRRZLT
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGKIX14.320.03
+0.21%
Morgan Stanley Global Permanence I
CSIFX46.280.04
+0.09%
Calvert Balanced A
JNVIX18.68-0.05
-0.27%
Jensen Quality Mid Cap I
NMVLX12.09-0.04
-0.33%
Nuance Mid Cap Value Institutional
PWJAX33.97-0.17
-0.50%
PGIM Jennison International Opps A

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
+3.45%
MGTX - ATYR
45%
Loosely correlated
N/A
IDYA - ATYR
42%
Loosely correlated
-2.26%
AURA - ATYR
41%
Loosely correlated
-5.76%
SLDB - ATYR
41%
Loosely correlated
+10.36%
RZLT - ATYR
40%
Loosely correlated
-2.71%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
-2.71%
RLAY - RZLT
47%
Loosely correlated
-4.11%
XNCR - RZLT
44%
Loosely correlated
-1.10%
CRNX - RZLT
41%
Loosely correlated
-5.78%
ATYR - RZLT
41%
Loosely correlated
+3.45%
TERN - RZLT
40%
Loosely correlated
+0.71%
More